BriMindInvest Logo

Viatris Inc. (VTRS) Stock Analysis 2026

HealthcareDrug Manufacturers - Specialty & Generic
$16.85
as of 2026-08-26

BriMind AI Score

Proprietary
27
Weak
Price CAGR
-7.7%
1Y Return
+53.2%
Analyst Upside
+13.4%
Rev Growth
4.9%

Score based on historical price CAGR, revenue growth, analyst upside, and valuation factors. Updated daily.

BriMind 1-Year Price Target

$17.86+6.0% potential
Bear Case
$12.51
Bull Case
$23.49
Model Confidence90%

BriMind AI combines DCF, momentum, and analyst consensus to project a 12-month price target.

AI scores and price targets are for informational and educational purposes only. They do not constitute financial advice or a recommendation to buy or sell any security. Past performance is not indicative of future results. Always conduct your own research before making investment decisions. Full Disclaimer →

VTRS Revenue & Profitability Breakdown

This chart shows how VTRS's revenue flows through to profit. Each row deducts a layer of costs: first the direct cost of making products/services (Cost of Revenue), then operating expenses like marketing and R&D, then taxes. What remains at the bottom is net income — the actual profit shareholders own. High gross and net margins indicate a business with strong pricing power and efficiency.

Revenue
$14.74B
Cost of Revenue
-$8.80B
Gross Profit
$5.94B40.3% margin
Operating Expenses
-$4.09B
Operating Income
$1.85B12.6% margin
Tax & Other
-$2.26B
Net Income
-$-410.7M-2.8% margin
Gross Margin
40.3%
Operating Margin
12.6%
Net Margin
-2.8%
EBITDA Margin
29.4%

Key Financial Metrics

Viatris Inc. doesn't carry a meaningful trailing P/E right now, generates $2.68B in free cash flow, runs a debt/equity ratio of 95.53, and converts shareholder equity into profit at a -2.8% return on equity. For context: P/E ratio measures how much you pay for $1 of earnings (lower = cheaper, but fast-growing companies command higher P/E); Free Cash Flow is the cash left after running the business; Debt/Equity shows how leveraged a company is; Return on Equity shows how efficiently it turns shareholder capital into profit.

Market Cap
$18.75B
Enterprise Value
$23.68B
P/E (Forward)
6.12
EV / EBITDA
5.62
Price / Sales
0.71
Price / Book
0.66
Revenue
$14.74B
Revenue Growth
4.9%
EBITDA
$4.22B
Gross Margin
40.3%
Operating Margin
12.6%
Net Margin
-2.8%
Return on Equity
-2.8%
Return on Assets
2.7%
Free Cash Flow
$2.68B
Total Cash
$1.00B
Total Debt
$14.46B
Debt / Equity
95.53
Current Ratio
1.58
Quick Ratio
0.82
Beta
0.89
Dividend Yield
2.9%
Payout Ratio
960.0%
Book Value / Share
$12.59

Wall Street Analyst Consensus

8 analysts covering Viatris Inc. currently lean toward a Hold rating, with a mean 12-month price target of $18.50 (+9.8% vs the current price). Analysts set these targets after researching a company's earnings, competitive position, and industry trends — Strong Buy / Buy means the majority expect meaningful upside, while Hold means fair value near the current price rather than a sell signal.

Consensus RatingHold(8 analysts)
SellStrong Buy
Low Target$8.00-52.5%
Mean Target$18.50+9.8% upside
High Target$14.00+-16.9%

Intrinsic Value Estimates for VTRS

Across the 1 valuation model available for VTRS, fair value estimates range from $47.90 to $47.90, averaging $47.90 — above the current $16.85 price. Intrinsic value is what a stock is truly worth based on the company's fundamentals, independent of what the market prices it at today. If multiple models agree the stock is undervalued, that convergence is a stronger signal.

DCF Model (10yr)
$47.90
+184.3% vs current
Discounts 10 years of projected free cash flow back to today's dollars (5% growth, 10% discount rate). Best for companies generating consistent cash.
Fair Value Range
$47.90 – $47.90
Average Estimate
$47.90
Potential Upside
184.3%

⚠️ Intrinsic value estimates use simplified models (Graham, DCF, P/E) and conservative assumptions. They should be used as one input among many — not as sole buy/sell guidance. For advanced analysis, see the full platform.

Unlock the Full VTRS Analysis

Interactive price charts, real-time AI signals, advanced DCF models, portfolio tracking, earnings analysis, and side-by-side peer comparisons. Start your 14-day free trial — no credit card required.

Start Free TrialBrowse All Stocks
Data sources: Financial metrics and market data sourced from company SEC filings, earnings releases, and investor relations disclosures. Price data, analyst consensus targets, and fundamental financials provided by financial market data providers. ETF data sourced from official fund prospectuses and index provider publications. AI scores and price targets are proprietary estimates — see our Methodology and Disclaimer for details.
← Back to Home · Browse All Stock Analysis